WE ARE DIGITIZING SMELL
The human nose still remains the best tool for assessing odors—whether through trained human panels or customer focus groups. But at Aryballe, we believe there is a better way. Traditional odor assessment equipment has been limited due to performance or reliability constraints. Aryballe’s bio-based approach using functionalized silicon photonics and machine learning delivers a consistent, reliable product for R&D, QC and operations. Whether it's detection or identification, Aryballe offers the right products to help your organization turn odor data into business assets.
LEADERSHIP TEAM
Sam Guilaumé
CEO
Sam is responsible for the overall strategic direction and investor relations for Aryballe. Prior to Aryballe, Sam was the co-founder and CEO of Movea, growing the company to the leading motion sensing technology and eventual acquisition by InvenSense, the leader in inertial sensors for consumer electronic applications. Sam brings over 20 years’ experience in the microelectronics industry to the Aryballe team.
BOARD MEMBER
Yanis Caritu
Chief Software Officer
Yanis is responsible for the development of Aryballe’s software platform, including the implementation of signal pre-processing, machine learning pipelines and graphical user interfaces to deliver odor data visualization and display to customers. Prior to Aryballe, Yanis was the founder and CTO of air quality start up eLichens and has held various senior technical roles at startups in the electronics industry, including co-founding Movea.
Thierry Chavigner
EVP Operations
Thierry is responsible for managing Aryballe’s manufacturing operations. He leads all aspects of manufacturing process development and supply chain relationships. Thierry has held various senior manufacturing roles leading start up organizations through a scaling of R&D to commercialization and has co-founded 3 companies in Europe and the US.
Tristan Rousselle
Founder & Deputy CEO
Tristan ensures the development of global strategic partnerships and customer relationships to meet Aryballe’s long term vision for the potential of digital olfaction. Prior to founding Aryballe, Tristan was the founder and CEO of PX’Therapeutics which specializes in the development of therapeutic proteins.
BOARD MEMBER
Delphine Pau
Chief Financial Officer
As CFO, Delphine is responsible for managing Aryballe financial systems and assets as well as managing the company’s recruitment, personnel and administrative systems. Previously, she was the head of HR at PX’Therapeutics.
Thierry Livache
Chief Scientific Officer & Special Projects
As Chief Scientific Officer, Thierry leads Aryballe’s breakthrough research strategic direction to develop next generation innovations for the company’s digital olfaction sensor platform. Previously he was Research Director at CEA and co-founder of two companies in the biomedical field. Thierry’s extensive background in biotechnology provides the foundation for Aryballe’s proprietary sensor technology.
Terri Jordan
EVP of Global Business Development & President of Aryballe, Inc.
Terri leads Aryballe’s client-relationship strategy to ensure product roadmaps meet market requirements and cultivates new partnerships aligned with long-term business goals. As the president of Aryballe, Inc, she is responsible for all operations of the US subsidiary. Previously, she was the Director of New Business Development for Asahi Kasei Corporate Ventures and has held senior commercial roles at a diverse group of companies including Fortune 500 and start-ups.
BOARD OF DIRECTORS
Pierre Chauvineau
Chairman of the Board
Following 30 years of executive leadership, Pierre now serves as a board member and advisor to a diverse range of deep tech startups, academic institutions and non-profit organizations. He began his career with Medtronic where he spent 20 years in various commercial roles. In 2010, Pierre joined Cameron Health, a venture-backed company based in California, and stayed with the company through its acquisition by Boston Scientific (BSC).
BOARD MEMBER
Catherine Dunand
Board Member
Catherine is the co-founder and president of CEMAG INVEST, a private equity firm focused on healthcare, B2B services and digital technology spaces. Prior to CEMAG INVEST, Catherine held senior leadership roles at a diverse group of companies both large and small, successfully conducting reorganization and M&A projects. As an independent board member for both listed and unlisted companies, she brings over three decades of experience in the areas of executive management, board membership and investment to these organizations.
BOARD MEMBER
Vincent Deltrieu
Board Member
Vincent is a partner and member of the board for INNOVACOM, a private equity firm focused on enabling new technology hardware and software start-ups. Vincent brings over 15 years of experience focused on digital and hi-tech solutions for a wide array of industries, including transportation, healthcare and smart homes. As a board member for both startups and SME’s, Vincent brings expertise in disruptive technology commercialization.
BOARD MEMBER
JOIN US
As a fast-growing startup, we are constantly looking for talented individuals to join us and help develop our products and customer relationships. Visit our careers page to see our open positions with links to apply online.
